Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$26.83
+6.5%
$19.33
$6.27
$27.51
$753.56M2.541.97 million shs1.50 million shs
Allient Inc. stock logo
ALNT
Allient
$44.37
-3.0%
$42.00
$16.91
$48.22
$775.49M1.51158,757 shs130,055 shs
Crawford United Corporation stock logo
CRAWA
Crawford United
$73.00
$61.06
$35.50
$73.20
$259.29M0.85638 shs51 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$14.19
+4.0%
$10.89
$3.91
$14.42
$940.86M1.93715,913 shs1.17 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
+6.51%+7.84%+47.42%+130.50%+102.03%
Allient Inc. stock logo
ALNT
Allient
-3.04%-1.86%+5.64%+27.68%+135.76%
Crawford United Corporation stock logo
CRAWA
Crawford United
0.00%0.00%-0.27%+48.98%+92.11%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+3.96%+20.97%+38.71%+61.07%+72.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$26.83
+6.5%
$19.33
$6.27
$27.51
$753.56M2.541.97 million shs1.50 million shs
Allient Inc. stock logo
ALNT
Allient
$44.37
-3.0%
$42.00
$16.91
$48.22
$775.49M1.51158,757 shs130,055 shs
Crawford United Corporation stock logo
CRAWA
Crawford United
$73.00
$61.06
$35.50
$73.20
$259.29M0.85638 shs51 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$14.19
+4.0%
$10.89
$3.91
$14.42
$940.86M1.93715,913 shs1.17 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
+6.51%+7.84%+47.42%+130.50%+102.03%
Allient Inc. stock logo
ALNT
Allient
-3.04%-1.86%+5.64%+27.68%+135.76%
Crawford United Corporation stock logo
CRAWA
Crawford United
0.00%0.00%-0.27%+48.98%+92.11%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+3.96%+20.97%+38.71%+61.07%+72.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
0.00
N/AN/AN/A
Allient Inc. stock logo
ALNT
Allient
2.00
Hold$35.00-21.12% Downside
Crawford United Corporation stock logo
CRAWA
Crawford United
0.00
N/AN/AN/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$26.8689.27% Upside

Current Analyst Ratings Breakdown

Latest CRAWA, EYPT, ALNT, and AEHR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$27.00
8/6/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$22.00 ➝ $23.00
6/17/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$28.00
(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$58.97M13.61$0.11 per share234.28$4.13 per share6.50
Allient Inc. stock logo
ALNT
Allient
$529.97M1.42$2.94 per share15.08$15.72 per share2.82
Crawford United Corporation stock logo
CRAWA
Crawford United
$150.20M1.73$5.42 per share13.47$20.44 per share3.57
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$43.27M22.60N/AN/A$4.93 per share2.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
-$3.91M-$0.13N/A121.95N/A-6.63%-0.15%-0.13%10/9/2025 (Estimated)
Allient Inc. stock logo
ALNT
Allient
$13.17M$0.8651.5924.25N/A2.75%9.97%4.67%11/5/2025 (Estimated)
Crawford United Corporation stock logo
CRAWA
Crawford United
$13.60M$4.3816.67N/A9.48%21.02%12.96%11/4/2025 (Estimated)
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$130.87M-$2.68N/AN/AN/A-337.93%-63.80%-50.72%11/6/2025 (Estimated)

Latest CRAWA, EYPT, ALNT, and AEHR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Allient Inc. stock logo
ALNT
Allient
$0.48$0.57+$0.09$0.34$132.89 million$139.58 million
8/6/2025Q2 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.67-$0.85-$0.18-$0.85$6.82 million$5.33 million
7/31/2025Q2 2025
Crawford United Corporation stock logo
CRAWA
Crawford United
$0.94$1.44+$0.50$1.44$40.20 million$46.85 million
7/8/2025Q4 2025
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
-$0.02-$0.01+$0.01-$0.10$14.83 million$14.10 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/AN/AN/AN/AN/A
Allient Inc. stock logo
ALNT
Allient
$0.120.27%N/A13.95%N/A
Crawford United Corporation stock logo
CRAWA
Crawford United
N/AN/AN/AN/AN/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A

Latest CRAWA, EYPT, ALNT, and AEHR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.3%8/21/20258/21/20259/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/A
5.68
2.99
Allient Inc. stock logo
ALNT
Allient
0.70
3.74
2.17
Crawford United Corporation stock logo
CRAWA
Crawford United
0.27
2.21
1.37
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
8.00
7.91

Institutional Ownership

CompanyInstitutional Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
69.69%
Allient Inc. stock logo
ALNT
Allient
61.57%
Crawford United Corporation stock logo
CRAWA
Crawford United
0.06%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%

Insider Ownership

CompanyInsider Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
6.20%
Allient Inc. stock logo
ALNT
Allient
14.90%
Crawford United Corporation stock logo
CRAWA
Crawford United
72.43%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
4.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
9029.92 million28.06 millionOptionable
Allient Inc. stock logo
ALNT
Allient
2,52516.95 million14.42 millionOptionable
Crawford United Corporation stock logo
CRAWA
Crawford United
4503.55 million979,000Not Optionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12068.93 million65.85 millionOptionable

Recent News About These Companies

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Hits New 12-Month High - What's Next?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aehr Test Systems stock logo

Aehr Test Systems NASDAQ:AEHR

$26.83 +1.64 (+6.51%)
Closing price 09/9/2025 04:00 PM Eastern
Extended Trading
$26.84 +0.01 (+0.02%)
As of 09/9/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.

Allient stock logo

Allient NASDAQ:ALNT

$44.37 -1.39 (-3.04%)
Closing price 09/9/2025 04:00 PM Eastern
Extended Trading
$44.38 +0.02 (+0.03%)
As of 09/9/2025 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

Crawford United stock logo

Crawford United OTCMKTS:CRAWA

$73.00 0.00 (0.00%)
As of 09/8/2025

Crawford United Corporation, together with its subsidiaries, provides specialty industrial products in the United States, Puerto Rico, Mexico, Canada, and internationally. It operates through two segments: Commercial Air Handling Equipment; and Industrial and Transportation Products. The Commercial Air Handling segment designs, manufactures, and installs large-scale commercial, institutional, and industrial custom air handling solutions to health care, education, pharmaceutical, and industrial manufacturing markets under the FactoryBilt and SiteBilt brand names. The Industrial and Transportation Products segment is involved in the manufacture of flexible interlocking metal hoses primarily to heavy-duty truck manufacturers and aftermarket suppliers, as well as to the agricultural, industrial, and petrochemical markets; and distribution of silicone and hydraulic hoses to the agriculture and general industrial markets. It also provides engineering, machining, grinding, welding, brazing, heat treat, and assembly solutions; rubber and plastic marine hose for the recreational boating industry; engineered manufacturing solutions, including CNC machining, anodizing, electro polishing, and laser marking for defense, aerospace, and medical device markets; and hydraulic hoses, air tank assemblies, and related products to manufacturers of firefighting trucks and other emergency vehicles. In addition, the company engages in the supply of highly engineered forgings for the aerospace, industrial gas turbine, medical prosthetics, alternative energy, petrochemical, and defense industries; and developing and commercializing marketing and data analytic technology applications. The company was formerly known as Hickok Incorporated and changed its name to Crawford United Corporation in May 2019. Crawford United Corporation was founded in 1910 and is headquartered in Cleveland, Ohio.

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$14.19 +0.54 (+3.96%)
Closing price 09/9/2025 04:00 PM Eastern
Extended Trading
$13.93 -0.26 (-1.83%)
As of 09/9/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.